News | TCTAP 2022
News TCTAP
News | TCTAP 2022
Is CABG the best approach for multivessel, left main CAD?
Mario F.L. Gaudino, MD says PCI and CABG are complementary - not antagonistic – strategies for patients with MVD, LMCAD
News | TCTAP 2022
¡®Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy¡¯
Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones
News | TCTAP 2022
Tailored de-escalation strategy in PCI and ACS: platelet function test and genetic test guidance
At TCTAP 2022, Dominick J. Angiolillo, MD outlines de-escalation strategies with PFT, genetic tests for PCI-ACS
News | TCTAP 2022
Can PCI save lives in severe LV dysfunction?
Divaka Perera, MD says REVIVED-BCIS2 to shed light on revascularization decisions for acute and chronic LV dysfunction
News | TCTAP 2022
Real issue in CABG vs PCI for left main? 'Balancing 'hard' outcomes with patient preferences'
Brian Bergmark, MD addresses real-life implications of meta-analysis that showed no mortality difference between PCI-CABG at TCTAP 2022
News | TCTAP 2022